Richard Day
Dr Richard Day is Professor of Clinical Pharmacology at UNSW and St Vincent's Hospital Sydney, and Director of Clinical Pharmacology and Toxicology at St Vincent's Hospital Sydney. He has a clinical practice in Clinical Pharmacology and Rheumatology and also a Pathology practice at St Vincents Hospital.
He was chairman of the Research Ethics Committee at St Vincents Hospital (1990-1996) and a member of the UNSW Ethics Committee. He sat on the Training Awards committee and the Research Ethics Subvommittee of the National Health and Medical Research Council of Australia (1995-1997). He was chairman of the review of the Clinical Trials Notification Scheme for the Federal Department of Health's Therapeutic Goods Association (1993) and has (1996/7) chaired a review of the Pharmaceutical Services Branch of the NSW Department of Health. He has been a the Board of the Medical Benefits Fund of Australia (1998-2002). He is a 3 year Director of the Drug Information Association (2001-2004) and convenes the Australasian Chapter of the DIA.
He has a particular interest in promoting the quality of use of medicines in the community which finds expression in membership of the Federal Government's Pharmaceutical Health & Rational Use of Medicines (PHARM 1991-3) Committee, the PHARM Industry and PHARM Consumer task forces, Co-investigator of the TREND project to enhance prescribing standards in General Practice, Chairmanship of the St Vincent's Hospital Drug Committee (1992-2002), Co-Director of the NSW Medicines Information Centre (MIC), membership of Australian Drug Evaluation Committee (ADEC 1991-96), independent member of the Australian Pharmaceutical Manufacturers' Association (APMA) Code of Conduct Subcommittee and Chairmanship of NSW Therapeutic Assessment Group (NSWTAG) (1995-2001).
He has research interests into the mechanisms and pharmacological treatments of the rheumatic diseases which have ranged across studies in inflammation, musculoskeletal pain, NSAIDs, antirheumatic drugs and hypouricaemic therapies. These interests are reflective of his clinical practice in rheumatology and clinical pharmacology.
Dr Day has developed a number of innovative approaches to teaching therapeutics to undergraduate medical students and extends his teaching activities to involve hospital doctors and general practitioners.
As a volunteer consultant to the UMC, he reviews the results of the regular computerised screenings of ADR reports within the System Organ Class of collagen disorders.
E-mail: r.day@unsw.edu.au |